Details for 2014867191
Up to date per 03.04.2026
Actions
Details for 2014867191
Granted/Registered
European Patent
12.10.2016 A
20.10.2021 B1
06.12.2013
US
201361913216 P
11.12.2013
US
201361914938 P
25.04.2014
US
201461984580 P
02.07.2014
US
201414322810
A61P 9/10 20060101AFI20210301BHEP
Owner
Nalpropion Pharmaceuticals LLC155 Franklin Rd, Suite 450 Brentwood, TN 37027US
Representative
Authorized Recipients
Georg Dr. KalhammerUnsöldstraße 280538 MünchenDE
Inventor
KLASSEN, Preston7762 Lookout Drive La Jolla, CA 92037US
TAYLOR, Kristin15023 Palomino Mesa Road San Diego, CA 92127US
Information about Fees